Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
13.55
+7.99 (143.71%)
At close: Nov 20, 2024, 4:00 PM
12.00
-1.55 (-11.44%)
Pre-market: Nov 21, 2024, 7:37 AM EST
Forte Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 20 | 30 | 21 | 32 | 467 | - | |
| Market Cap Growth | -66.02% | 42.17% | -33.49% | -93.24% | - | - | |
| Enterprise Value | 3 | -16 | -23 | -14 | 447 | - | |
| Last Close Price | 13.55 | 20.54 | 25.00 | 53.50 | 910.25 | - | |
| PB Ratio | 2.11 | 0.85 | 0.54 | 0.76 | 7.92 | - | |
| P/TBV Ratio | 0.87 | 0.85 | 0.54 | 0.76 | 7.92 | - | |
| Quick Ratio | 1.91 | 10.13 | 12.93 | 23.92 | 26.01 | 3.63 | |
| Current Ratio | 2.06 | 10.45 | 13.06 | 24.19 | 26.52 | 3.93 | |
| Return on Equity (ROE) | -137.40% | -84.92% | -34.54% | -43.19% | -143.64% | -76.28% | |
| Return on Assets (ROA) | -67.66% | -50.15% | -20.36% | -25.69% | -25.81% | -39.91% | |
| Return on Capital (ROIC) | -89.48% | -54.78% | -21.61% | -26.72% | -27.47% | -47.62% | |
| Earnings Yield | -172.83% | -105.42% | -66.09% | -68.75% | -9.95% | - | |
| FCF Yield | -150.25% | -96.44% | -38.98% | -52.82% | -3.94% | - | |
| Buyback Yield / Dilution | -82.51% | -81.61% | -24.45% | -89.81% | -249.05% | 76.47% | |
| Total Shareholder Return | -82.51% | -81.61% | -24.45% | -89.81% | -249.05% | 76.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.